Astellas Archives -

https://pharmaphorum.com/news/nice-backs-nhs-use-for-astellas-xospata-after-rethink/

GSK’s kidney disease anaemia drug approved in Japan, taking on Astellas’ rival

https://pharmaphorum.com/news/gsk-kidney-disease-anaemia-drug-approved-in-japan-taking-on-astellas-rival/

Seattle Genetics says data backs Padcev combo for first-line bladder cancer

https://pharmaphorum.com/news/seattle-genetics-says-data-backs-padcev-combo-for-first-line-bladder-cancer/

Xtandi takes fight to prostate cancer rivals with survival data

https://pharmaphorum.com/news/xtandi-takes-fight-to-prostate-cancer-rivals-with-survival-data/

Astellas to work with Adaptimmune to develop ‘off the shelf’ T-cell therapies

https://pharmaphorum.com/news/astellas-to-work-with-adaptimmune-to-develop-off-the-shelf-t-cell-therapies/

FDA backs Astellas/Seattle Genetics bladder cancer drug

https://pharmaphorum.com/news/fda-backs-astellas-seattle-genetics-bladder-cancer-drug/

Xtandi catches up with Erleada in castration-sensitive prostate cancer

https://pharmaphorum.com/news/xtandi-catches-up-with-erleada-in-castration-sensitive-prostate-cancer/

Patient-partnered drug discovery: vision or reality?

https://deep-dive.pharmaphorum.com/magazine/patient-engagement/astellas-patient-partnered-drug-discovery-vision-or-reality/

Astellas buys gene therapy company for $3bn

https://pharmaphorum.com/news/astellas-acquires-gene-therapy-company-for-3bn/

Search